The Controversial Epidemiology of Left Ventricular Dysfunction in Patients With Myotonic Dystrophy Type 1
- 1 September 2017
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 2 (9) , 1044
Abstract
To the Editor In a recent issue of JAMA Cardiology, we read with great interest the report of Tanawuttiwat et al1 entitled “Left Ventricular Dysfunction and Conduction Disturbances in Patients With Myotonic Muscular Dystrophy Type I and II.” In their well-written research letter, the authors described the baseline prevalence and longitudinal incidence of conduction abnormalities and left ventricular dysfunction in a large single-center cohort of patients with myotonic muscular dystrophy type 1 and type 2 (DM1 and DM2). The authors defined left ventricular dysfunction (LVD) as an ejection fraction less than 55%, which differs from previous studies that used cutoffs of 50% or less. They reported a prevalence of left ventricular dysfunction at baseline in patients with DM1 of 11.8%, with an incidence of 2% during the follow-up period (mean, 5.76 years).Keywords
This publication has 4 references indexed in Scilit:
- Left Ventricular Dysfunction and Conduction Disturbances in Patients With Myotonic Muscular Dystrophy Type I and IIJAMA Cardiology, 2017
- High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: A cross-sectional studyInternational Journal of Cardiology, 2014
- Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1American Heart Journal, 2010
- Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1New England Journal of Medicine, 2008